Skip to content

Low intensity psychological support for people with personality disorder: Randomised controlled trial

Assessing a Low Intensity Treatment for Enduring personality-related problems

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14994755
Enrollment
60
Registered
2017-07-18
Start date
2017-07-13
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Mental Health, Primary sub-specialty: Personality Disorders

Interventions

Participants with a diagnosis of personality disorder are randomised to receive either treatment as usual or low intensity psychological support. The randomisation list is generated by the independent

Sponsors

Central and North West London NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 or over 2. Clinical diagnosis of personality disorder 3. Positive screening result using the International Personality Disorder Examination self-administered questionnaire 4. Competent and willing to provide written, informed consent

Exclusion criteria

Exclusion criteria: 1. A current clinical diagnosis of a co-existing organic or psychotic mental disorder (dementia, bipolar affective disorder (type I and II), delusional disorder, schizophrenia, schizoaffective disorder or schizotypal disorder 2. Cognitive or language difficulties that would preclude subjects providing informed consent or compromise participation in study procedures

Design outcomes

Primary

MeasureTime frame
Feasibility of the study is measured using the following: 1. Recruitment of at least 80% of the study sample i.e 48 participants from the total of 60 we are aiming to recruit. 2. Uptake of the low intensity intervention by at least 60% of participants in the active arm of the trial i.e. 18 of the 30 who are randomised to the low intensity intervention will have received it according to feedback from the therapist assigned to the participant. 3. Completion of follow-up interviews at six months by 75% of study participants. To determine the feasibility of calculating a cost analysis of health economics, we will record completion rates for the cost data, and analyse them to determine what the cost-drivers are likely to be if proceeding to a full clinical trial.

Secondary

MeasureTime frame
1. Impairment of functioning is measured using the Work and Social Adjustment Scale at baseline and six months 2. Mental health is assessed using the participant-completed Warwick and Edinburgh Well-Being Schedule at baseline and six months 3. Suicidal thoughts and behaviour is measured using Four questions on suicidal thoughts and behaviour taken from the national household survey of psychiatric morbidity at baseline and six months 4. Health-related quality of life is measured using the EuroQol Five Dimensions (EQ-5D) at baseline and six months 5. Satisfaction with care is assessed using the participant-completed four-item Client Satisfaction Questionnaire at baseline and six months 6. Resource use and costs are assessed using a modified version of the Adult Service User Schedule (AD-SUS) at baseline and six months 7. Change in overall health is measured using the patient version of the Clinical Global Impression Scale at baseline and six months

Countries

United Kingdom

Contacts

Public ContactAmy Claringbold
a.claringbold@imperial.ac.uk+44 20 8383 4134

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 5, 2026